A fluorescence-based assay for core 1 β3Galactosyltransferase (T-Synthase) activity

Methods in Molecular Biology

Volumn 1022, Issue , 2013, Pages 15-28

  Ju, Tongzhong ^a   Cummings, Richard D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

4 MU; Core 1 b3galactosyltransferase; Fluorescent assay; O glycans; T synthase

Indexed keywords

BUFFER; DISACCHARIDE; ENZYME; HYMECROMONE; O GLYCOSIDASE; T SYNTHASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GALACTOSE; WATER;

ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; FLUORESCENCE; FLUORESCENCE BASED ASSAY; PH; PRIORITY JOURNAL;

EID: 84880472385     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-465-4_2     Document Type: Article

References (34)

1. Leppanen A, Mehta P, Ouyang YB, Ju T, Helin J, Moore KL, van Die I, Canfield WM, McEver RP, Cummings RD (1999) A novel glycosulfopeptide binds to P-selectin and inhibits leukocyte adhesion to P-selectin. J Biol Chem 274(35):24838-24848
2. Sperandio M (2006) Selectins and glycosyltransferases in leukocyte rolling in vivo. FEBS J 273(19):4377-4389
3. McEver RP, Cummings RD (1997) Role of PSGL-1 binding to selectins in leukocyte recruitment J Clin Invest 100(11 Suppl): S97-S103
4. McEver RP, Cummings RD (1997) Perspectives series: Cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment J Clin Invest 100(3):485-491
5. Leppanen A, Yago T, Otto VI, McEver RP, Cummings RD (2003) Model glycosulfopeptides from P-selectin glycoprotein ligand-1 require tyrosine sulfation and a core 2-branched O-glycan to bind to L-selectin. J Biol Chem 278(29):26391-26400
6. Yeh JC, Hiraoka N, Petryniak B, Nakayama J, Ellies LG, Rabuka D, Hindsgaul O, Marth JD, Lowe JB, Fukuda M (2001) Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1,3-N- Acetylglucosaminyltransferase. Cell 105(7):957-969
7. Fukuda M, Carlsson SR (1986) Leukosialin, a major sialoglycoprotein on human leukocytes as differentiation antigens. Med Biol 64(6):335-343
8. Xia L, Ju T, Westmuckett A, An G, Ivanciu L, McDaniel JM, Lupu F, Cummings RD, McEver RP (2004) Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1-derived O-glycans. J Cell Biol 164(3): 451-459
9. Fu J, Gerhardt H, McDaniel JM, Xia B, Liu X, Ivanciu L, Ny A, Hermans K, Silasi-Mansat R, McGee S, Nye E, Ju T, Ramirez MI, Carmeliet P, Cummings RD, Lupu F, Xia L (2008) Endothelial cell O-glycan defi ciency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Invest 118(11):3725-3737
10. Ju T, Brewer K, D?Souza A, Cummings RD, Canfield WM (2002) Cloning and expression of human core 1 beta1,3-galactosyltransferase. J Biol Chem 277(1):178-186
11. Berger EG (1999) Tn-syndrome. Biochim Biophys Acta 1455(2-3):255-268
12. Cartron JP, Nurden AT (1979) Galactosyltransferase and membrane glycoprotein abnormality in human platelets from Tn-syndrome donors. Nature 282(5739): 621-623
13. Allen AC, Topham PS, Harper SJ, Feehally J (1997) Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant 12(4):701-706
14. Blanchard B, Nurisso A, Hollville E, Tetaud C, Wiels J, Pokorna M, Wimmerova M, Varrot A, Imberty A (2008) Structural basis of the preferential binding for globo-series glycosphingolipids displayed by Pseudomonas aeruginosa lectin I. J Mol Biol 383(4):837-853
15. Springer GF (1984) T and Tn, general carcinoma autoantigens. Science 224(4654): 1198-1206
16. Springer GF, Taylor CR, Howard DR, Tegtmeyer H, Desai PR, Murthy SM, Felder B, Scanlon EF (1985) Tn, a carcinomaassociated antigen, reacts with anti-Tn of normal human sera. Cancer 55(3):561-569
17. Ju T, Aryal RP, Stowell CJ, Cummings RD (2008) Regulation of protein O-glycosylation by the endoplasmic reticulum-localized molecular chaperone Cosmc. J Cell Biol 182(3): 531-542
18. Ju T, Cummings RD (2002) A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci U S A 99(26):16613-16618
19. Wang Y, Ju T, Ding X, Xia B, Wang W, Xia L, He M, Cummings RD (2010) Cosmc is an essential chaperone for correct protein O-glycosylation. Proc Natl Acad Sci USA 107(20):9228-9233
20. Aryal RP, Ju T, Cummings RD (2010) The endoplasmic reticulum chaperone Cosmc directly promotes in vitro folding of T-synthase. J Biol Chem 285(4):2456-2462
21. Ju T, Cummings RD (2005) Protein glycosylation: Chaperone mutation in Tn syndrome. Nature 437(7063):1252
22. Ju T, Lanneau GS, Gautam T, Wang Y, Xia B, Stowell SR, Willard MT, Wang W, Xia JY, Zuna RE, Laszik Z, Benbrook DM, Hanigan MH, Cummings RD (2008) Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Res 68(6):1636-1646
23. Crew VK, Singleton BK, Green C, Parsons SF, Daniels G, Anstee DJ (2008) New mutations in C1GALT1C1 in individuals with Tn positive phenotype. Br J Haematol 142(4): 657-667
24. Schietinger A, Philip M, Yoshida BA, Azadi P, Liu H, Meredith SC, Schreiber H (2006) A mutant chaperone converts a wild-Type protein into a tumor-specifi c antigen. Science 314
25. Furukawa K, Roth S (1985) Co-purifi cation of galactosyltransferases from chick-embryo liver. Biochem J 227(2):573-582
26. Granovsky M, Bielfeldt T, Peters S, Paulsen H, Meldal M, Brockhausen J, Brockhausen I (1994) UDPgalactose:glycoprotein-N-Acetyl-D-galactosamine 3-beta-D-galactosyltransferase activity synthesizing O-glycan core 1 is controlled by the amino acid sequence and glycosylation of glycopeptide substrates. Eur J Biochem 221(3):1039-1046
27. Ju T, Cummings RD, Canfield WM (2002) Purifi cation, characterization, and subunit structure of rat core 1 Beta1,3-galactosyltransferase. J Biol Chem 277(1):169-177
28. Mendicino J, Sivakami S, Davila M, Chandrasekaran EV (1982) Purifi cation and properties of UDP-gal:N-Acetylgalactosaminide mucin: Beta 1,3-galactosyltransferase from swine trachea mucosa. J Biol Chem 257(7):3987-3994
29. Ju T, Xia B, Aryal RP, Wang W, Wang Y, Ding X, Mi R, He M, Cummings RD (2011) A novel fl uorescent assay for T-synthase activity. Glycobiology 21(3):352-362
30. Inoue T, Sugiyama H, Hiki Y, Takiue K, Morinaga H, Kitagawa M, Maeshima Y, Fukushima K, Nishizaki K, Akagi H, Narimatsu Y, Narimatsu H, Makino H (2010) Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy. Clin Immunol 136(3):447-455
31. Yamada K, Kobayashi N, Ikeda T, Suzuki Y, Tsuge T, Horikoshi S, Emancipator SN, Tomino Y (2010) Down-regulation of core 1 beta1,3- galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1. Nephrol Dial Transplant 25(12): 3890-3897
32. Qin W, Zhong X, Fan JM, Zhang YJ, Liu XR, Ma XY (2008) External suppression causes the low expression of the Cosmc gene in IgA nephropathy. Nephrol Dial Transplant 23(5):1608-1614
33. Qin W, Zhou Q, Yang LC, Li Z, Su BH, Luo H, Fan JM (2005) Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy. J Intern Med 258(5):467-477
34. Mead JA, Smith JN, Williams RT (1955) Studies in detoxication. 67. The biosynthesis of the glucuronides of umbelliferone and 4-methylumbelliferone and their use in fl uorimetric determination of beta-glucuronidase. Biochem J 61(4):569-574